Rexahn Pharmaceuticals, Inc. (RNN) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down almost 38% in the past one-month time frame.
In the last 7 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rexahn currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Gentium S.p.A (GENT), Emergent BioSolutions, Inc. (EBS) and Actelion Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
REXAHN PHARMACEUTICALS INC (RNN): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Health Care Industry